MORPHOSYS AG O.N.

Bid 28,13 EUR
Ask 28,30 EUR

Premiumpartner

Firmenbeschreibung

Die MorphoSys AG ist ein globales, kommerziell ausgerichtetes Biopharma-Unternehmen. MorphoSys vermarktet sein eigenes Medikament Monjuvi in den USA – eine Krebsimmuntherapie in Kombination mit Lenalidomid für die Zweit- und Drittlinien-Behandlung von Patienten mit diffusem großzelligen B-Zell-Lymphom (DLBCL), die nicht für eine Stammzellentherapie in Frage kommen. Tafasitamab wird zudem in einer globalen Studie als mögliche Erstlinientherapie bei DLBCL untersucht. Zwei weitere Produktkandidaten für onkologische Indikationen befinden sich in der späten und mittleren klinischen Entwicklungsphase: Pelabresib, ein selektiver niedermolekularer BET-Inhibitor, wird als potenzielle Behandlungsmöglichkeit für Myelofibrose entwickelt – eine Form von Knochenmarkkrebs mit begrenzten Behandlungsmöglichkeiten; und CPI-0209, ein EZH2-Hemmer der zweiten Generation, der zur Behandlung hämatologischer und solider Tumore untersucht wird. MorphoSys hat seinen Hauptsitz in Planegg bei München und führt sein Geschäft in den USA von Boston, Massachusetts.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Freefloat (70.6%),Baillie Gifford & Co (6.23%),Royalty Pharma PLC (3.91%),Schroders plc (3.03%),Invesco Ltd. (2.997%),T. Rowe Price Group, Inc. (2.99%),Artisan Partners Asset Management Inc. (2.95%),Templeton Funds Trust (2.8469%),BlackRock, Inc. (2.45%),JPMorgan Chase & Co. (2%)
sharesOutstanding: 34232000.0000
ceo: Dr. Jean-Paul Kress
board: Sung Lee, Dr. Malte Peters, Dr. Roland Wandeler
supervisoryBoard: Dr. Marc Cluzel, Dr. George Golumbeski, Krisja Vermeylen, Michael Brosnan, Sharon Curran, Wendy Johnson
countryID: 2
freeFloat: 70.6000
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Biotechnologie
industryName: Biotechnologie
subsectorName: Biotechnologie
country: Deutschland
countryName: Deutschland

Kontakt

name: Dr. Julia Neugebauer
phone: +49-89-89927-26972
email: investors@morphosys.com
irWebSite: is.gd/2t8YM2

Adresse

street: Semmelweisstr. 7
city: D-82152 Martinsried/Planegg
phone: +49-89-89927-0
fax: +49-89-89927-222
webSite: www.morphosys.de
email: info@morphosys.de

Finanzen (kurz)

year: 2019 cash: 44.3000
balanceSheetTotal: 496.4000 liabilities: 101.7000
totalShareholdersEquity: 394.7000 sales: 71.8000
investment: 2.8000 incomeBeforeTaxes: -106.5000
netIncome: -103.0000 cashFlow: -1.1000
employees: 426 currencyID: 1
units: 1000000 currency: EUR
year: 2020 cash: 109.8000
balanceSheetTotal: 1659.5000 liabilities: 1038.2000
totalShareholdersEquity: 621.3000 sales: 327.7000
investment: 92.0000 incomeBeforeTaxes: 22.5000
netIncome: 97.9000 cashFlow: 66.2000
employees: 615 currencyID: 1
units: 1000000 currency: EUR
year: 2021 cash: 123.2000
balanceSheetTotal: 2556.3000 liabilities: 2311.4000
totalShareholdersEquity: 244.9000 sales: 179.6000
investment: 96.6000 incomeBeforeTaxes: -591.1000
netIncome: -514.5000 cashFlow: 13.5000
employees: 732 currencyID: 1
units: 1000000 currency: EUR

Finanzen (kurz)

year: 2019
cash: 44.3000
balanceSheetTotal: 496.4000
liabilities: 101.7000
totalShareholdersEquity: 394.7000
sales: 71.8000
investment: 2.8000
incomeBeforeTaxes: -106.5000
netIncome: -103.0000
cashFlow: -1.1000
employees: 426
currencyID: 1
units: 1000000
currency: EUR
year: 2020
cash: 109.8000
balanceSheetTotal: 1659.5000
liabilities: 1038.2000
totalShareholdersEquity: 621.3000
sales: 327.7000
investment: 92.0000
incomeBeforeTaxes: 22.5000
netIncome: 97.9000
cashFlow: 66.2000
employees: 615
currencyID: 1
units: 1000000
currency: EUR
year: 2021
cash: 123.2000
balanceSheetTotal: 2556.3000
liabilities: 2311.4000
totalShareholdersEquity: 244.9000
sales: 179.6000
investment: 96.6000
incomeBeforeTaxes: -591.1000
netIncome: -514.5000
cashFlow: 13.5000
employees: 732
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2020 units: 1000000
balanceSheetTotal: 1659.5000 cash: 109.8000
currentAssets: 1206.8000 liabilities: 200.5000
nonCurrentLiabilities: 837.7000 totalLiabilitiesEquity: 1659.5000
provisions: 72.3000 totalShareholdersEquity: 621.3000
employees: 615 property: 6.3000
intangibleAssets: 113.7000 longTermInvestments: 196.6000
inventories: 10.0000 accountsReceivable: 83.4000
currentSecurities: 42.9000 accountsPayable: 128.6000
liabilitiesBanks: 516.4000 liabilitiesTotal: 1038.2000
longTermDebt: 516.4000 sales: 327.7000
netIncome: 97.9000 operatingResult: 27.4000
incomeInterest: -4.2000 investments: 141.4000
incomeTaxes: -75.4000 materialCosts: 9.2000
personnelCosts: 131.9000 costGoodsSold: 141.1000
grossProfit: 186.6000 revenuePerEmployee: 532845.5285
cashFlow: 35.3000 cashFlowInvesting: -879.6000
cashFlowFinancing: 907.2000 cashFlowTotal: 66.2000
equityRatio: 37.4390 debtEquityRatio: 167.1012
liquidityI: 76.1596 liquidityII: 117.7556
netMargin: 29.8749 grossMargin: 56.9423
cashFlowMargin: 10.7720 ebitMargin: 8.3613
ebitdaMargin: 0.0000 preTaxROE: 3.6214
preTaxROA: 1.3558 roe: 15.7573
roa: 5.8994 revenuesGrowth: 356.4067
taxExpenseRate: -335.1111 equityTurnover: 0.5274
epsBasic: 3.0100 epsDiluted: 2.9700
shareCapital: 32.8900 incomeBeforeTaxes: 22.5000
priceEarningsRatioCompany: 31.1694 priceCashFlowRatio: 87.4147
dividendYield: 0.0000 bookValuePerShare: 18.8902
marketCap: 3085739800.0000 earningsYield: 3.2083
cashFlowPerShare: 1.0733 priceBookValueRatio: 4.9666
dividendsPerShare: 0.0000 priceEarningsRatio: 31.5193
netEarningsPerShare: 2.9766 currency: EUR
year: 2021 units: 1000000
balanceSheetTotal: 2556.3000 cash: 123.2000
currentAssets: 1133.0000 liabilities: 284.5000
nonCurrentLiabilities: 2026.8000 totalLiabilitiesEquity: 2556.3000
provisions: 26.7000 totalShareholdersEquity: 244.9000
employees: 732 property: 7.1000
intangibleAssets: 880.8000 longTermInvestments: 0.0000
inventories: 20.8000 accountsReceivable: 75.9000
currentSecurities: 16.7000 accountsPayable: 188.1000
liabilitiesBanks: 1681.1000 liabilitiesTotal: 2311.4000
longTermDebt: 1681.1000 sales: 179.6000
netIncome: -514.5000 operatingResult: -506.5000
incomeInterest: -84.9000 investments: 455.9000
incomeTaxes: -76.6000 materialCosts: 32.2000
personnelCosts: 171.1000 costGoodsSold: 203.3000
grossProfit: -23.7000 revenuePerEmployee: 245355.1913
cashFlow: -481.4000 cashFlowInvesting: -831.0000
cashFlowFinancing: 1322.9000 cashFlowTotal: 13.5000
equityRatio: 9.5803 debtEquityRatio: 943.8138
liquidityI: 49.1740 liquidityII: 75.8524
netMargin: -286.4699 grossMargin: -13.1960
cashFlowMargin: -268.0401 ebitMargin: -282.0156
ebitdaMargin: 0.0000 preTaxROE: -241.3638
preTaxROA: -23.1233 roe: -210.0857
roa: -20.1267 netIncomeGrowth: -625.5363
revenuesGrowth: -45.1938 taxExpenseRate: 12.9589
equityTurnover: 0.7334 epsBasic: -15.4000
epsDiluted: -15.4000 epsBasicGrowth: -611.6279
shareCapital: 34.2320 incomeBeforeTaxes: -591.1000
priceCashFlowRatio: -2.3715 dividendYield: 0.0000
bookValuePerShare: 7.1541 marketCap: 1141637200.0000
earningsYield: -46.1769 cashFlowPerShare: -14.0629
priceBookValueRatio: 4.6616 dividendsPerShare: 0.0000
netEarningsPerShare: -15.0298 currency: EUR
year: 2022 priceCashFlowRatio: -1.9932
dividendYield: 0.0000 bookValuePerShare: 7.1541
marketCap: 959522960.0000 earningsYield: -54.9411
pegRatio: 0.0030 cashFlowPerShare: -14.0629
priceBookValueRatio: 3.9180 netEarningsPerShare: -15.0298
currency: EUR

Finanzen (ausführlich)

year: 2020
units: 1000000
balanceSheetTotal: 1659.5000
cash: 109.8000
currentAssets: 1206.8000
liabilities: 200.5000
nonCurrentLiabilities: 837.7000
totalLiabilitiesEquity: 1659.5000
provisions: 72.3000
totalShareholdersEquity: 621.3000
employees: 615
property: 6.3000
intangibleAssets: 113.7000
longTermInvestments: 196.6000
inventories: 10.0000
accountsReceivable: 83.4000
currentSecurities: 42.9000
accountsPayable: 128.6000
liabilitiesBanks: 516.4000
liabilitiesTotal: 1038.2000
longTermDebt: 516.4000
sales: 327.7000
netIncome: 97.9000
operatingResult: 27.4000
incomeInterest: -4.2000
investments: 141.4000
incomeTaxes: -75.4000
materialCosts: 9.2000
personnelCosts: 131.9000
costGoodsSold: 141.1000
grossProfit: 186.6000
revenuePerEmployee: 532845.5285
cashFlow: 35.3000
cashFlowInvesting: -879.6000
cashFlowFinancing: 907.2000
cashFlowTotal: 66.2000
equityRatio: 37.4390
debtEquityRatio: 167.1012
liquidityI: 76.1596
liquidityII: 117.7556
netMargin: 29.8749
grossMargin: 56.9423
cashFlowMargin: 10.7720
ebitMargin: 8.3613
ebitdaMargin: 0.0000
preTaxROE: 3.6214
preTaxROA: 1.3558
roe: 15.7573
roa: 5.8994
revenuesGrowth: 356.4067
taxExpenseRate: -335.1111
equityTurnover: 0.5274
epsBasic: 3.0100
epsDiluted: 2.9700
shareCapital: 32.8900
incomeBeforeTaxes: 22.5000
priceEarningsRatioCompany: 31.1694
priceCashFlowRatio: 87.4147
dividendYield: 0.0000
bookValuePerShare: 18.8902
marketCap: 3085739800.0000
earningsYield: 3.2083
cashFlowPerShare: 1.0733
priceBookValueRatio: 4.9666
dividendsPerShare: 0.0000
priceEarningsRatio: 31.5193
netEarningsPerShare: 2.9766
currency: EUR
year: 2021
units: 1000000
balanceSheetTotal: 2556.3000
cash: 123.2000
currentAssets: 1133.0000
liabilities: 284.5000
nonCurrentLiabilities: 2026.8000
totalLiabilitiesEquity: 2556.3000
provisions: 26.7000
totalShareholdersEquity: 244.9000
employees: 732
property: 7.1000
intangibleAssets: 880.8000
longTermInvestments: 0.0000
inventories: 20.8000
accountsReceivable: 75.9000
currentSecurities: 16.7000
accountsPayable: 188.1000
liabilitiesBanks: 1681.1000
liabilitiesTotal: 2311.4000
longTermDebt: 1681.1000
sales: 179.6000
netIncome: -514.5000
operatingResult: -506.5000
incomeInterest: -84.9000
investments: 455.9000
incomeTaxes: -76.6000
materialCosts: 32.2000
personnelCosts: 171.1000
costGoodsSold: 203.3000
grossProfit: -23.7000
revenuePerEmployee: 245355.1913
cashFlow: -481.4000
cashFlowInvesting: -831.0000
cashFlowFinancing: 1322.9000
cashFlowTotal: 13.5000
equityRatio: 9.5803
debtEquityRatio: 943.8138
liquidityI: 49.1740
liquidityII: 75.8524
netMargin: -286.4699
grossMargin: -13.1960
cashFlowMargin: -268.0401
ebitMargin: -282.0156
ebitdaMargin: 0.0000
preTaxROE: -241.3638
preTaxROA: -23.1233
roe: -210.0857
roa: -20.1267
netIncomeGrowth: -625.5363
revenuesGrowth: -45.1938
taxExpenseRate: 12.9589
equityTurnover: 0.7334
epsBasic: -15.4000
epsDiluted: -15.4000
epsBasicGrowth: -611.6279
shareCapital: 34.2320
incomeBeforeTaxes: -591.1000
priceCashFlowRatio: -2.3715
dividendYield: 0.0000
bookValuePerShare: 7.1541
marketCap: 1141637200.0000
earningsYield: -46.1769
cashFlowPerShare: -14.0629
priceBookValueRatio: 4.6616
dividendsPerShare: 0.0000
netEarningsPerShare: -15.0298
currency: EUR
year: 2022
priceCashFlowRatio: -1.9932
dividendYield: 0.0000
bookValuePerShare: 7.1541
marketCap: 959522960.0000
earningsYield: -54.9411
pegRatio: 0.0030
cashFlowPerShare: -14.0629
priceBookValueRatio: 3.9180
netEarningsPerShare: -15.0298
currency: EUR